Literature DB >> 31913513

Evidence Regarding Medication Overuse Headache in Children and Adolescents: Protocol for a Systematic Review.

Juliana VanderPluym1, Jessica Gautreaux2, Rebecca Burch3, Evans Whitaker4, Jason Roberts5, Dana P Turner6, Amy A Gelfand7.   

Abstract

OBJECTIVES: This proposed systematic review will identify the existing evidence on medication-overuse headache in children and adolescents.
BACKGROUND: A number of medications have been shown to be effective for acute treatment of migraine in children and adolescents. However, patients may find they need to use their acute medications more frequently when migraine frequency is high. This has led to concern about their potential to develop medication-overuse headache.
METHODS: We will search PubMed, Embase, Web of Science, PsycINFO, and Cochrane databases from their inception to present time. We will also search conference proceedings of the last 4 scientific meetings of relevant societies and scan the reference lists of studies identified through the search. Study designs will include case series, cross-sectional, cohort, case-control, and interventional studies. Participants will include children and adolescents under 18 years of age with primary headache disorders. We aim to determine whether frequency of acute medication use is associated with headache frequency in children and adolescents. Outcomes of interest include: (1) headache frequency; (2) change in headache frequency, with time and in relationship to use of acute medications; and (3) headache-related disability. We will also review data addressing treatment/management of medication overuse or medication-overuse headache in children and adolescents. Relevant comparators will be withdrawal vs reduction of acute medication, initiation of preventive therapy vs no initiation with or without withdrawal of acute medication, and initiation of preventive therapy early vs late. Outcomes of interest include (1) days of acute medication use; (2) headache frequency; (3) change in headache frequency; and (4) headache-related disability. After screening for inclusion, 2 team members will independently review and extract relevant data, and any discrepancies will be resolved through discussion and arbitration. We will assess risk of bias using appropriate tools (Cochrane Risk of Bias for randomized controlled trials (RCT) and Newcastle-Ottawa Score for observational studies). Data will be summarized descriptively in text and tables.
RESULTS: This systematic review will provide an overview of the available evidence on medication-overuse headache in children and adolescents.
CONCLUSIONS: Findings from this review will aid clinicians by clarifying for them the current state of the evidence base, and will inform design of future research on this topic.
© 2019 American Headache Society.

Entities:  

Keywords:  medication-overuse headache; migraine; pediatric migraine

Mesh:

Year:  2020        PMID: 31913513     DOI: 10.1111/head.13726

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  3 in total

1.  Pediatric Headache in Primary Care and Emergency Departments: Consensus with RAND/UCLA Method.

Authors:  Giovanni Prezioso; Agnese Suppiej; Valentina Alberghini; Patrizia Bergonzini; Maria Elena Capra; Ilaria Corsini; Alessandro De Fanti; Elisa Fiumana; Martina Fornaro; Lucia Marangio; Paolo Ricciardelli; Laura Serra; Duccio Maria Cordelli; Susanna Esposito
Journal:  Life (Basel)       Date:  2022-01-19

2.  Over-the-counter analgesics use is associated with pain and psychological distress among adolescents: a mixed effects approach in cross-sectional survey data from Norway.

Authors:  Rune Jonassen; Eva Hilland; Catherine J Harmer; Dawit S Abebe; Anne Kristine Bergem; Siv Skarstein
Journal:  BMC Public Health       Date:  2021-11-06       Impact factor: 3.295

Review 3.  Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?

Authors:  Robert C Gibler; Kaelynn E Knestrick; Brooke L Reidy; Daniel N Lax; Scott W Powers
Journal:  Pediatric Health Med Ther       Date:  2022-09-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.